Study on Female Patients' Mammographic Texture Features

NCT06469606 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2024-06-21

No results posted yet for this study

Summary

Mammography is the most common method for breast imaging, and it provides information for model building and analysis. Radiomics applied to mammography has the potential to revolutionize clinical decision-making by providing valuable insights into risk assessment and disease detection. Despite this, the influence of imaging parameters and clinical and biological factors on radiological texture features remains poorly understood. There is a pressing need to overcome the obstacle of system-inherent effects on mammographic images to facilitate the translation of radiological texture features into routine clinical practice by enabling reliable and robust AI-based or AI-aided decision-making. Furthermore, understanding the relationship between imaging parameters, textural features, and clinical and biological information supports the clinical use of AI. The objective of this study is to evaluate AI methods for clinical practice and to study how it relates to clinical factors and biological features.

Conditions

Interventions

DEVICE

AI tool

Both the arms will undergo the use of "AI tool" developed in the group. The tool will be trained to detect outcomes.

Sponsors & Collaborators

  • Tampere University

    collaborator OTHER
  • Kuopio University Hospital

    collaborator OTHER
  • University of Eastern Finland

    collaborator OTHER
  • University of Turku

    collaborator OTHER
  • University of Oulu

    collaborator OTHER
  • Tampere University Hospital

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-17
Primary Completion
2035-12-15
Completion
2038-12-15

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06469606 on ClinicalTrials.gov